The estimated Net Worth of Edward J Rapp is at least $911 Tysiąc dollars as of 3 March 2020. Mr. Rapp owns over 2,875 units of Abbvie Inc stock worth over $559,446 and over the last 17 years he sold ABBV stock worth over $0. In addition, he makes $352,029 as Independent Director at Abbvie Inc.
Edward has made over 22 trades of the Abbvie Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently he bought 2,875 units of ABBV stock worth $252,626 on 3 March 2020.
The largest trade he's ever made was exercising 60,000 units of Abbvie Inc stock on 31 January 2014 worth over $2,317,800. On average, Edward trades about 2,637 units every 36 days since 2008. As of 3 March 2020 he still owns at least 2,875 units of Abbvie Inc stock.
You can see the complete history of Mr. Rapp stock trades at the bottom of the page.
Edward J. Rapp is an Independent Director of the Company. Mr. Rapp served as the Caterpillar Inc. group president for resource industries from 2014 until his retirement in mid-2016. He previously served at Caterpillar as group president based in Singapore in 2013 and 2014 and as the chief financial officer from 2010 to 2013, and he was named a group president in 2007. Mr. Rapp is presently a board member for FM Global. He is currently a member of the University of Missouri College of Business Strategic Development Board.
As the Independent Director of Abbvie Inc, the total compensation of Edward Rapp at Abbvie Inc is $352,029. There are 13 executives at Abbvie Inc getting paid more, with Richard Gonzalez having the highest compensation of $21,610,600.
Edward Rapp is 61, he's been the Independent Director of Abbvie Inc since 2013. There are 10 older and 22 younger executives at Abbvie Inc. The oldest executive at Abbvie Inc is Edward Liddy, 73, who is the Independent Director.
Edward's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell oraz Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Abbvie Inc executives and other stock owners filed with the SEC include: